Therapeutic alliance

NYU Langone Health and Deerfield Management Launch Amethyst Innovations with Up To $130 Million to Accelerate Commercialization of Biomedical Discoveries

Retrieved on: 
Tuesday, June 6, 2023
Partnership, Therapy, Therapeutic alliance, NYU Langone Health, NYU, Woman, Research, History, Translation, Organization, Women in science, Investigational New Drug, Patient, Economic development, Knowledge, Ecosystem, IND, Pharmaceutical industry, Medical device

NEW YORK, June 6, 2023 /PRNewswire/ -- NYU Langone Health and Deerfield Management Company, a healthcare investment firm, today announced the launch of a research and development collaboration designed to accelerate the commercialization of biomedical discoveries. 

Key Points: 
  • NEW YORK, June 6, 2023 /PRNewswire/ -- NYU Langone Health and Deerfield Management Company, a healthcare investment firm, today announced the launch of a research and development collaboration designed to accelerate the commercialization of biomedical discoveries.
  • "This collaboration will give our researchers new options to bring promising biomedical innovations into treatments and cures that will address some of the world's most pressing health issues.
  • Amethyst Innovations, LLC, a private company wholly owned by affiliates of Deerfield Management, will support NYU Langone research projects in various stages of drug exploration and development.
  • Under the terms of the agreement, Amethyst Innovations, LLC would receive an option to license Amethyst Innovations-funded intellectual property developed at NYU Langone.

Crossover Health Shares New Research at ATA 2023 on Virtual PT and Hybrid Care

Retrieved on: 
Friday, March 3, 2023
Integration, Population Health Management, DPT, Conference, Virtual, Education, System, SAN, Value, Population health, Goodness, PSFS, Glossary, Research, GOF, Therapeutic alliance, Nursing, MD

Crossover Health Medical Group leaders will unveil research results pertaining to areas experiencing limited study: comparing virtual care to in-person care and the value of hybrid care for population health management.

Key Points: 
  • Crossover Health Medical Group leaders will unveil research results pertaining to areas experiencing limited study: comparing virtual care to in-person care and the value of hybrid care for population health management.
  • "The Value of Integrating In-person and Virtual Care for Population Health Management in Employer-Sponsored Primary Care Settings," will be presented by Yvonne Robinson-Hawkins, MD, National Virtual Care Team Physician at Crossover Health.
  • Results found that outcomes improved under a hybrid care model, which offers flexibility and choice in addressing population health needs.
  • Crossover Health has been an industry leader in the delivery of both virtual and onsite care through its unique and highly effective hybrid care approach.

Panel Event: How to Measure and Improve Therapeutic Alliance

Retrieved on: 
Tuesday, February 14, 2023
General Health, Health, Mental Health, Other Health, MBC, Therapeutic alliance, National Clinical Impact Award, Medical device, Dietary supplement, Research

Research shows that therapeutic alliance is one of the most important predictors of positive symptom change for people in care.

Key Points: 
  • Research shows that therapeutic alliance is one of the most important predictors of positive symptom change for people in care.
  • It is also one of the most commonly used assessments amongst Measurement-Based Care (MBC) service providers.
  • In this panel, Dr. Mallinckrodt will share the importance of a strong client-clinician relationship, the three vital components of a working alliance, and how to best use the BR-WAI in practice.
  • Emily Miller will also share examples of improving the therapeutic alliance in practice, the results she’s seen throughout treatment, and the impact the measure has made on client and clinic outcomes.